Table 3.
Adjusted Multivariable Analysis | Any Complicationa 95% CI |
Clavien IV or V Complicationa 95% CI |
|||||||
---|---|---|---|---|---|---|---|---|---|
Variableb | OR | Low | High | p-value | OR | Low | High | p-value | |
Sex | Female | Reference | Reference | ||||||
Male | 1.03 | 0.93 | 1.13 | 0.59 | 1.37 | 1.11 | 1.69 | <0.01 | |
Age | <50 | Reference | Reference | ||||||
50–59 | 1.11 | 0.96 | 1.29 | 0.14 | 1.57 | 1.04 | 2.39 | 0.03 | |
60–69 | 1.16 | 1.01 | 1.33 | <0.01 | 1.72 | 1.15 | 2.56 | 0.01 | |
70–79 | 1.35 | 1.17 | 1.55 | <0.01 | 2.70 | 1.81 | 4.03 | <0.01 | |
≥80 | 1.73 | 1.47 | 2.02 | <0.01 | 3.98 | 2.62 | 6.04 | <0.01 | |
Race | Caucasian | Reference | Reference | ||||||
African-American | 1.07 | 0.94 | 1.22 | 0.30 | 1.22 | 0.92 | 1.61 | 0.17 | |
Hispanic | 0.92 | 0.79 | 1.07 | 0.29 | 0.71 | 0.48 | 1.04 | 0.08 | |
Asian | 0.93 | 0.70 | 1.24 | 0.61 | 0.90 | 0.45 | 1.78 | 0.76 | |
Year | 2006 | Reference | Reference | ||||||
2007 | 1.12 | 0.48 | 2.61 | 0.79 | 0.79 | 0.10 | 6.41 | 0.82 | |
2008 | 1.08 | 0.47 | 2.46 | 0.86 | 1.58 | 0.21 | 11.95 | 0.66 | |
2009 | 1.10 | 0.48 | 2.49 | 0.83 | 1.57 | 0.21 | 11.80 | 0.66 | |
2010 | 1.50 | 0.66 | 3.40 | 0.33 | 1.30 | 0.17 | 9.74 | 0.80 | |
2011 | 1.55 | 0.68 | 3.51 | 0.29 | 1.35 | 0.18 | 10.10 | 0.77 | |
ASA Class | 1 | Reference | Reference | ||||||
2 | 1.39 | 1.09 | 1.77 | 0.01 | 4.13 | 1.01 | 16.90 | 0.05 | |
3 | 1.89 | 1.48 | 2.42 | <0.01 | 8.03 | 1.96 | 32.83 | <0.01 | |
4 | 2.81 | 2.13 | 3.72 | <0.01 | 13.72 | 3.30 | 57.11 | <0.01 | |
Functional Status | Independent | Reference | Reference | ||||||
Partially Dependent | 1.76 | 1.47 | 2.09 | <0.01 | 2.31 | 1.72 | 3.11 | <0.01 | |
Totally Dependent | 3.03 | 2.04 | 4.52 | <0.01 | 6.76 | 4.06 | 11.26 | <0.01 | |
COPD | 1.23 | 1.09 | 1.40 | <0.01 | 1.52 | 1.21 | 1.92 | <0.01 | |
Steroid | 1.25 | 1.03 | 1.51 | 0.02 | 1.51 | 1.07 | 2.14 | 0.02 | |
AKI | 2.70 | 1.89 | 3.87 | <0.01 | 3.38 | 2.01 | 5.69 | <0.01 | |
Bleeding Risk | 1.44 | 1.20 | 1.71 | <0.01 | 1.22 | 0.86 | 1.74 | 0.26 | |
Preop Transfusion | 4.44 | 3.40 | 5.80 | <0.01 | 1.64 | 1.03 | 2.62 | 0.04 | |
HTN | 1.06 | 0.99 | 1.14 | 0.11 | 1.06 | 0.89 | 1.26 | 0.49 | |
Diabetes | 1.05 | 0.96 | 1.15 | 0.26 | 1.13 | 0.10 | 1.35 | 0.94 | |
| |||||||||
Residentc | Not case-mix adjusted | 1.43 | 1.34 | 1.53 | <0.01 | 1.62 | 1.39 | 1.90 | <0.01 |
Residentc | Case-mix adjusted | 1.18 | 1.09 | 1.29 | <0.01 | 1.06 | 0.88 | 1.28 | 0.55 |
Scrotal | 0.98 | 0.54 | 1.77 | 0.95 | N/A | ||||
Transurethral | 1.01 | 0.88 | 1.18 | 0.84 | 0.88 | 0.61 | 1.29 | 0.53 | |
Urogynecologic | 1.70 | 1.18 | 2.45 | <0.01 | N/A | ||||
Abdominopelvic | 1.23 | 1.10 | 1.38 | <0.01 | 1.12 | 0.88 | 1.41 | 0.36 |
Also adjusted for case-mix of procedures; 95% CI = 95% confidence interval; OR = odds ratio
ASA = American Society of Anesthesiologists; COPD = chronic obstructive pulmonary disease; AKI = acute kidney injury; HTN = hypertension
Subset analysis of 77% of procedures including data on resident assistance; abdominopelvic includes prostatectomy, nephrectomy, and cystectomy; scrotal and urogynecologic surgeries had too small of a sample size and low rate of Clavien 4 or 5 complications to analyze.